In last trading session, Kintara Therapeutics Inc (NASDAQ:KTRA) saw 1.89 million shares changing hands with its beta currently measuring 0.41. Company’s recent per share price level of $0.15 trading at -$0.01 or -4.70% at ring of the bell on the day assigns it a market valuation of $8.18M. That closing price of KTRA’s stock is at a discount of -3886.67% from its 52-week high price of $5.98 and is indicating a premium of 46.67% from its 52-week low price of $0.08. Taking a look at company’s average trading volume volume of 14.88 million if we extend that period to 3-months.

Kintara Therapeutics Inc (NASDAQ:KTRA) trade information

Upright in the red during last session for losing -4.70%, in the last five days KTRA remained trading in the green while hitting it’s week-highest on Friday, 04/26/24 when the stock touched $0.15 price level, adding 23.08% to its value on the day. Kintara Therapeutics Inc’s shares saw a change of -12.74% in year-to-date performance and have moved 7.79% in past 5-day. Kintara Therapeutics Inc (NASDAQ:KTRA) showed a performance of 47.41% in past 30-days.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of -$ for the same. And 1 analysts are in estimates of company making revenue of -$ in the next quarter that will end on Dec 2023. Company posted -$ and -$ of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 49.09% during past 5 years.

KTRA Dividends

Kintara Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.